Back to search results

Research Assistant

Swansea University - Swansea University Medical School

Location: Llandysul
Salary: £30,046 to £33,797 per annum together with USS pension benefits, Grade 07
Hours: Full Time
Contract Type: Fixed-Term/Contract
Placed On: 7th April 2021
Closes: 6th May 2021
Job Ref: AC04490

Contract: This is a fixed term position until 31st October 2022. Full-time.

Location: Ig Innovations in Llandysul

The role is based on the need to develop and validate novel, scalable, affinity purification technologies for the detection and characterisation of exosome populations. The post holder will be responsible for the integration of immunoassays for these biomarkers into the IgInnovations exosome platform – complementing existing protein chemistries, assay development/validation pipelines.  The assays will be developed in collaboration between Swansea, Reneuron Ltd and IgInnovations Ltd, and validated in collaboration with SBUHB Health Board

The purpose of this role is to develop new technological assays for exosome detection, purification and subsequent characterization, in conjunction with commercial partners. The post holder will be knowledgeable in the area of novel technologies applied to medical applications. The RA will be employed by Swansea University in the Reproductive Biology Group in the School of Medicine at Swansea University. The post holder will be based mainly at the industrial partner facilities of Ig-Innovations where they will undertake assay and purification development work, having access to a wide range of facilities, equipment and expertise.  The post holder will be the main liaison between academia and industry.

The role is based on the need to develop and validate novel, scalable, affinity purification technologies for the detection and characterisation of exosome populations. The post holder will be responsible for the integration of immunoassays for these biomarkers into the IgInnovations exosome platform – complementing existing protein chemistries, assay development/validation pipelines.  The assays will be developed in collaboration between Swansea, Reneuron Ltd and IgInnovations Ltd, and validated in collaboration with SBUHB Health Board

The post requires significant input to study design, set-up, implementation, data analysis / interpretation and reporting. The individual will have expertise in protein chemistry, assay validation, a good knowledge in chromatography as well as a basic understanding in cell and molecular biology. Joining a multidisciplinary team, the post will enable delivery of the main research themes of the RISE programme, including industry scale exosome production, purification, characterisation and applications development in the area of novel therapeutics in an oncology setting. 

To apply for the post please click on the link: here

Applicants are asked to provide a completed online application providing clear evidence against the essential criteria in the recruitment documentation.

For further information please contact Dr Lewis Francis l.francis@swansea.ac.uk

Closing Date: 6th May 2021

‘This fixed term 100% FTE post has been funded for the period 05/04/2021 to 31/10/2022 by the SMART Expertise2014-2020, West Wales and the Valleys programme via the European Regional Development Fund funded 2017/COL/001 ReNeuron, IgInnovations and Swansea University development of Exosomes towards clinical utility”.

We value your feedback on the quality of our adverts. If you have a comment to make about the overall quality of this advert, or its categorisation then please send us your feedback
Advert information

Type / Role:

Subject Area(s):

Location(s):

Job tools
 
 
 
More jobs from Swansea University

Show all jobs for this employer …

More jobs like this
Join in and follow us

Browser Upgrade Recommended

jobs.ac.uk has been optimised for the latest browsers.

For the best user experience, we recommend viewing jobs.ac.uk on one of the following:

Google Chrome Firefox Microsoft Edge